10% Owner New Enterprise Associates Makes $15M Open Market Purchase Post-IPO

summarizeSummary

A 10% owner, New Enterprise Associates 17, L.P., purchased $15 million worth of SpyGlass Pharma common stock on the open market, complementing a series of insider buys following the company's IPO.

check_boxKey Events

• Significant Open Market Purchase

  New Enterprise Associates 17, L.P., a 10% owner, acquired 937,500 shares of common stock for $15,000,000.00 at a price of $16.00 per share on February 9, 2026.

• Post-IPO Insider Accumulation

  This purchase is part of a broader pattern of significant insider accumulation, with multiple 10% owners and a director collectively buying $84.8 million in stock this week following SpyGlass Pharma's IPO.

• Preferred Stock Conversion

  The filing also reported the automatic conversion of 5,097,538 shares of various series of preferred stock into common stock, a standard event prior to the company's initial public offering.

auto_awesomeAnalysis

New Enterprise Associates 17, L.P., a significant 10% owner, demonstrated strong confidence in SpyGlass Pharma, Inc. by making a substantial $15 million open market purchase of common stock. This transaction, occurring shortly after the company's IPO and alongside a cluster of other insider buys, signals robust institutional backing and positive sentiment from key investors. The purchase price of $16.00 per share is notably below the current market price, suggesting the insider saw significant value at the time of the transaction. The conversion of preferred stock to common stock is a routine event associated with the IPO, but the cash purchase represents new capital deployment and a direct investment decision.